Sequential therapy in patients receiving Fluoroquinolones at the American University of Beirut Medical Center. (c2001)

Availability of oral antibiotics with superior pharmacokinetic profiles and safety has enabled early conversion from parenteral to oral antibiotic therapy in attempt to reduce overall cost. In Lebanon, no hospital has set guidelines regarding switching from intravenous (IV) to oral (PO) antibiotics....

Full description

Saved in:
Bibliographic Details
Main Author: Homsi, Maria (author)
Format: masterThesis
Published: 2001
Subjects:
Online Access:http://hdl.handle.net/10725/560
https://doi.org/10.26756/th.2001.6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513454262452224
author Homsi, Maria
author_facet Homsi, Maria
author_role author
dc.creator.none.fl_str_mv Homsi, Maria
dc.date.none.fl_str_mv 2001
2001-10-11
2011-09-14T11:13:31Z
2011-09-14T11:13:31Z
2011-09-14
dc.identifier.none.fl_str_mv http://hdl.handle.net/10725/560
https://doi.org/10.26756/th.2001.6
dc.language.none.fl_str_mv en
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Antibiotics -- Therapeutic use
Antibiotics -- Physiological effect
dc.title.none.fl_str_mv Sequential therapy in patients receiving Fluoroquinolones at the American University of Beirut Medical Center. (c2001)
dc.type.none.fl_str_mv Thesis
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/masterThesis
description Availability of oral antibiotics with superior pharmacokinetic profiles and safety has enabled early conversion from parenteral to oral antibiotic therapy in attempt to reduce overall cost. In Lebanon, no hospital has set guidelines regarding switching from intravenous (IV) to oral (PO) antibiotics. The objective of this study was to evaluate such practice at a tertiary care medical center. Patients admitted to AUBMC, receiving intravenous ciprofloxacin, levofloxacin, or ofloxacin were enrolled prospectively. Variables were collected daily from admission until discharge, including antibiotics prescribed, vital signs, CBC, and cultures. Date of switch (if applicable), oral antibiotic chosen, mean time to switch, mean hospital duration, and mean treatment duration were also recorded. Patients were evaluated for appropriateness of switch according to set guidelines summarized from previously published data. 195 patients were divided into three groups depending on the quinolone prescribed. Patients were then divided into two groups: treatment and prophylaxis, in which there were 124 and 71 patients respectively. Only 54.8% were switched. 53.6% of patients not switched could have been eligible candidates for oral therapy. Mean time to switch was 4.7 days, 4.6 days, and 3.6 days for the ofloxacin, levofloxacin, and ciprofloxacin groups respectively. While the mean time to switch was similar in the three groups, ciprofloxacin patients had a slightly longer duration of treatment at home. Identification of hospitalized patients eligible for switch therapy should be a target for intervention to hospitals in effort to decrease cost.
eu_rights_str_mv openAccess
format masterThesis
id LAURepo_586f2cd5496b41e81a54d67cee21bf92
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/560
publishDate 2001
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Sequential therapy in patients receiving Fluoroquinolones at the American University of Beirut Medical Center. (c2001)Homsi, MariaAntibiotics -- Therapeutic useAntibiotics -- Physiological effectAvailability of oral antibiotics with superior pharmacokinetic profiles and safety has enabled early conversion from parenteral to oral antibiotic therapy in attempt to reduce overall cost. In Lebanon, no hospital has set guidelines regarding switching from intravenous (IV) to oral (PO) antibiotics. The objective of this study was to evaluate such practice at a tertiary care medical center. Patients admitted to AUBMC, receiving intravenous ciprofloxacin, levofloxacin, or ofloxacin were enrolled prospectively. Variables were collected daily from admission until discharge, including antibiotics prescribed, vital signs, CBC, and cultures. Date of switch (if applicable), oral antibiotic chosen, mean time to switch, mean hospital duration, and mean treatment duration were also recorded. Patients were evaluated for appropriateness of switch according to set guidelines summarized from previously published data. 195 patients were divided into three groups depending on the quinolone prescribed. Patients were then divided into two groups: treatment and prophylaxis, in which there were 124 and 71 patients respectively. Only 54.8% were switched. 53.6% of patients not switched could have been eligible candidates for oral therapy. Mean time to switch was 4.7 days, 4.6 days, and 3.6 days for the ofloxacin, levofloxacin, and ciprofloxacin groups respectively. While the mean time to switch was similar in the three groups, ciprofloxacin patients had a slightly longer duration of treatment at home. Identification of hospitalized patients eligible for switch therapy should be a target for intervention to hospitals in effort to decrease cost.1 bound copy: 64 p. available at RNL.2011-09-14T11:13:31Z2011-09-14T11:13:31Z20012011-09-142001-10-11Thesisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesishttp://hdl.handle.net/10725/560https://doi.org/10.26756/th.2001.6eninfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/5602017-09-25T07:06:57Z
spellingShingle Sequential therapy in patients receiving Fluoroquinolones at the American University of Beirut Medical Center. (c2001)
Homsi, Maria
Antibiotics -- Therapeutic use
Antibiotics -- Physiological effect
status_str publishedVersion
title Sequential therapy in patients receiving Fluoroquinolones at the American University of Beirut Medical Center. (c2001)
title_full Sequential therapy in patients receiving Fluoroquinolones at the American University of Beirut Medical Center. (c2001)
title_fullStr Sequential therapy in patients receiving Fluoroquinolones at the American University of Beirut Medical Center. (c2001)
title_full_unstemmed Sequential therapy in patients receiving Fluoroquinolones at the American University of Beirut Medical Center. (c2001)
title_short Sequential therapy in patients receiving Fluoroquinolones at the American University of Beirut Medical Center. (c2001)
title_sort Sequential therapy in patients receiving Fluoroquinolones at the American University of Beirut Medical Center. (c2001)
topic Antibiotics -- Therapeutic use
Antibiotics -- Physiological effect
url http://hdl.handle.net/10725/560
https://doi.org/10.26756/th.2001.6